Xcelerate Inc.
XCRT
$0.027
$0.00010.37%
| Weiss Ratings | XCRT - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Rating | ||||
| Reward Index | Very Weak | |||
| Risk Index | Very Weak | |||
| Risk Grade | E+ | |||
| Reward Grade | E | |||
| Rating Factors | XCRT - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Index | -- | |||
| Growth Index | Weak | |||
| Efficiency Index | Very Weak | |||
| Solvency Index | Very Weak | |||
| Total Return Index | Very Weak | |||
| Volatility Index | Weak | |||
| Beta / Standard Deviation | XCRT - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Beta | 0.38 | |||
| Price History | XCRT - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| 7-Day Total Return | 0.75% | |||
| 30-Day Total Return | 86.21% | |||
| 60-Day Total Return | 42.11% | |||
| 90-Day Total Return | 25.58% | |||
| Year to Date Total Return | 28.57% | |||
| 1-Year Total Return | -39.05% | |||
| 2-Year Total Return | -30.77% | |||
| 3-Year Total Return | -47.57% | |||
| 5-Year Total Return | 1,700.00% | |||
| 52-Week High % Change | -48.27% | |||
| 52-Week Low % Change | 278.87% | |||
| Price | XCRT - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| 52-Week High Price | $0.05 | |||
| 52-Week Low Price | $0.01 | |||
| 52-Week Low Price (Date) | Nov 14, 2024 | |||
| 52-Week High Price (Date) | Jul 26, 2024 | |||
| Valuation | XCRT - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Market Cap | 11.69M | |||
| Enterprise Value | 13.17M | |||
| Price/Earnings (TTM) | -- | |||
| Earnings Per Share (TTM) | 0.00 | |||
| Earnings Per Share Growth | -33.33% | |||
| Price/Earnings To Growth | -- | |||
| Price/Sales (TTM) | 4.34 | |||
| Price/Book (Q) | -20.69 | |||
| Enterprise Value/Revenue (TTM) | 4.88 | |||
| Price | $0.03 | |||
| Enterprise Value/EBITDA (TTM) | -9.87 | |||
| Enterprise Value/EBIT | -8.97 | |||
| Market Cap Category | Nano Cap | |||
| Dividends and Shares | XCRT - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Shares Outstanding | 434.45M | |||
| Dividend Yield | -- | |||
| Div. Per Share (Most Recent) | -- | |||
| Dividend Per Share (TTM) | -- | |||
| Payout Ratio (TTM) | -- | |||
| Dividend Per Share (Most Recent) | -- | |||
| Company Info | XCRT - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Phone Number | 854 900 2020 | |||
| Address | 110 Renaissance Circle Mauldin, SC 29662 | |||
| Website | www.xcelerate.global | |||
| Country | United States | |||
| Year Founded | 1996 | |||
| Profitability | XCRT - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Operating Margin (TTM) | -54.37% | |||
| Profit Margin | -49.82% | |||
| Management Effectiveness | XCRT - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Return on Assets | -85.76% | |||
| Return on Equity | -- | |||
| Income Statement | XCRT - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Revenue (TTM) | 2.70M | |||
| Total Revenue (TTM) | 2.70M | |||
| Revenue Per Share | $0.01 | |||
| Gross Profit (TTM) | 605.90K | |||
| EBITDA (TTM) | -1.33M | |||
| EBIT (TTM) | -1.47M | |||
| Net Income (TTM) | -1.35M | |||
| Net Income Avl. to Common (TTM) | -1.35M | |||
| Total Revenue Growth (Q YOY) | -- | |||
| Earnings Growth (Q YOY) | 82.50% | |||
| EPS Diluted (TTM) | 0.00 | |||
| EPS Diluted Growth (Q YOY) | 86.11% | |||
| Balance Sheet | XCRT - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Cash and Short-Term Inv. (Q) | 110.50K | |||
| Cash Per Share (Q) | $0.00 | |||
| Total Current Assets (Q) | 858.30K | |||
| Total Preferred Equity (Q) | 0.00 | |||
| Total Equity (Q) | -657.20K | |||
| Current Ratio (Q) | 0.345 | |||
| Book Value Per Share (Q) | $0.00 | |||
| Total Assets (Q) | 1.83M | |||
| Total Current Liabilities (Q) | 2.49M | |||
| Total Debt (Q) | 1.71M | |||
| Total Liabilities (Q) | 2.49M | |||
| Total Common Equity (Q) | -544.00K | |||
| Cash Flow | XCRT - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Cash from Investing (TTM) | -266.40K | |||
| Cash from Financing (TTM) | 1.35M | |||
| Net Change in Cash (TTM) | 104.90K | |||
| Levered Free Cash Flow (TTM) | -299.50K | |||
| Cash from Operations (TTM) | -978.80K | |||
